received advisory/consulting fees and/or other support from Altimmune, AstraZeneca, Bayer, Biomea, Boehringer Ingelheim, Carmot Therapeutics, Cytoki Pharma, Eli Lilly, Intercept, Janssen/Johnson & Johnson, Mannkind, Mediflix, Merck, Metsera, Novo Nordisk, Pharmaventures, Pfizer, Regeneron, Sanofi, Shionogi, Structure Therapeutics, Target RWE, Terns Pharmaceuticals, The Comm Group, Valeritas, WebMD and Zealand Pharma
18 Other factors implicated in this theory are obesity, lower limb alignment abnormalities, soft tissue insufficiency and anatomical variants such as discoid meniscus, 19 greater posterior and medial tibial slope, 20 smaller intercondylar notch 21 and more distal location of posterior cruciate ligament
Healthcare professionals should refer to the latest clinical trial data and regulatory updates when considering managing weight or other therapeutic purposes
Q5: Can I use GHK-Cu powder directly on skin